| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5572131 | Clinical Nutrition | 2016 | 7 Pages |
Abstract
These results show that Kefir has a potential to modulate the immune response and activate peritoneal macrophages in diabetic animals, which suggests that it could enhance the immunocompetence of patients affected by diabetes mellitus. The hypoglycemic effect of this probiotic could be used as a tool to control glycemia, reducing or delaying the onset of complications associated with this disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Fabiane R. Maciel, Giovana R. Punaro, Adelson M. Rodrigues, Cristina S.B. Bogsan, Marcelo M. Rogero, Marice N. Oliveira, Margaret G. Mouro, Elisa M.S. Higa,